CASTING her enchanting eye over a year of uncertainty and instability our AI-powered version of the legendary mystic Baba ...

Alien: Earth finally brought the franchise, famously set in space where no-one can hear you scream, to our TV screens last year, introducing a whole host of creepy creatures while dealing with plenty ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...